Rigel Pharmaceuticals Q1 2025 Earnings Preview
Source: SeekingAlpha
2025-05-05 17:20:34 ET
More on Rigel Pharmaceuticals
- Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability
- Rigel Looks Interesting, But Let's Wait For A Lower Price
- Rigel Pharmaceuticals, Inc. (RIGL) Q4 2024 Earnings Call Transcript
- Rigel settles patent litigation regarding its immune thrombocytopenia treatment
- Rigel Pharmaceuticals appoints Mark W. Frohlich to board of directors
Read the full article on Seeking Alpha
For further details see:
Rigel Pharmaceuticals Q1 2025 Earnings Preview
Rigel Pharmaceuticals Inc.
NASDAQ: RIGL
RIGL Trading
-3.13% G/L:
$26.0825 Last:
96,605 Volume:
$26.87 Open:
RIGL Latest News
March 03, 2026 04:01:00 pm
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
RIGL Stock Data
$625,132,287
16,430,597
0.07%
54
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
